Top

Published in:

01-10-2016 | Cardiovascular Genomics (TL Assimes, Section Editor)

Genetics and Genomics of Coronary Artery Disease

Authors: Milos Pjanic, Clint L. Miller, Robert Wirka, Juyong B. Kim, Daniel M. DiRenzo, Thomas Quertermous

Published in: Current Cardiology Reports | Issue 10/2016

Abstract

Coronary artery disease (or coronary heart disease), is the leading cause of mortality in many of the developing as well as the developed countries of the world. Cholesterol-enriched plaques in the heart’s blood vessels combined with inflammation lead to the lesion expansion, narrowing of blood vessels, reduced blood flow, and may subsequently cause lesion rupture and a heart attack. Even though several environmental risk factors have been established, such as high LDL-cholesterol, diabetes, and high blood pressure, the underlying genetic composition may substantially modify the disease risk; hence, genome composition and gene-environment interactions may be critical for disease progression. Ongoing scientific efforts have seen substantial advancements related to the fields of genetics and genomics, with the major breakthroughs yet to come. As genomics is the most rapidly advancing field in the life sciences, it is important to present a comprehensive overview of current efforts. Here, we present a summary of various genetic and genomics assays and approaches applied to coronary artery disease research.

Kuska B. Beer, Bethesda, and biology: how “genomics” came into being. J Natl Cancer Inst. 1998;90(2):93.PubMedCrossRef

2.••

Consortium, C.A.D. A comprehensive 1000 genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet. 2015;47(10):1121–30. This study provides a largest GWAS meta-analysis for the coronary artery disease including 60,801 cases and 123,504 controls from 48 individual GWAS studies.CrossRef

Consortium CAD et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33.

Park DS et al. Adapt-Mix: learning local genetic correlation structure improves summary statistics-based analyses. Bioinformatics. 2015;31(12):i181–9.PubMedPubMedCentralCrossRef

Gagliano SA et al. A Bayesian method to incorporate hundreds of functional characteristics with association evidence to improve variant prioritization. PLoS One. 2014;9(5):e98122.PubMedPubMedCentralCrossRef

Manolio TA et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747–53.PubMedPubMedCentralCrossRef

Zuk O et al. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci U S A. 2012;109(4):1193–8.PubMedPubMedCentralCrossRef

Farh KK et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337–43.PubMedCrossRef

Kichaev G et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 2014;10(10):e1004722.PubMedPubMedCentralCrossRef

10.

Trynka G et al. Disentangling the effects of colocalizing genomic annotations to functionally prioritize non-coding variants within complex-trait loci. Am J Hum Genet. 2015;97(1):139–52.PubMedPubMedCentralCrossRef

11.

Cordell HJ. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet. 2009;10(6):392–404.PubMedPubMedCentralCrossRef

12.

Wang IM et al. Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol. 2012;8:594.PubMedPubMedCentralCrossRef

13.

Makinen VP et al. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet. 2014;10(7):e1004502.PubMedPubMedCentralCrossRef

14.

Huan T et al. A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler Thromb Vasc Biol. 2013;33(6):1427–34.PubMedPubMedCentralCrossRef

15.•

Miller CL, Pjanic M, Quertermous T. From locus association to mechanism of gene causality: the devil is in the details. Arterioscler Thromb Vasc Biol. 2015;35(10):2079–80. This editorial provides a good overview of methods to identify causal variation and causal genes, and reviews a recent paper in the field.PubMedCrossRef

16.

Kwon SM et al. Perspectives of integrative cancer genomics in next generation sequencing era. Genome Inform. 2012;10(2):69–73.CrossRef

17.

Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet. 2010;11(7):476–86.PubMedPubMedCentral

18.

Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57–63.PubMedPubMedCentralCrossRef

19.

Trapnell C et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28(5):511–5.PubMedPubMedCentralCrossRef

20.

Zhao S et al. Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS One. 2014;9(1):e78644.PubMedPubMedCentralCrossRef

21.

Wang C et al. The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat Biotechnol. 2014;32(9):926–32.PubMedPubMedCentralCrossRef

22.

McPherson A et al. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol. 2011;7(5):e1001138.PubMedPubMedCentralCrossRef

23.

van de Geijn B et al. WASP: allele-specific software for robust molecular quantitative trait locus discovery. Nat Methods. 2015;12(11):1061–3.PubMedPubMedCentralCrossRef

24.

Mayba O et al. MBASED: allele-specific expression detection in cancer tissues and cell lines. Genome Biol. 2014;15(8):405.PubMedPubMedCentralCrossRef

25.

Pirinen M et al. Assessing allele-specific expression across multiple tissues from RNA-seq read data. Bioinformatics. 2015;31(15):2497–504.PubMedPubMedCentralCrossRef

26.

Sen SK et al. Integrative DNA, RNA, and protein evidence connects TREML4 to coronary artery calcification. Am J Hum Genet. 2014;95(1):66–76.PubMedPubMedCentralCrossRef

27.

Liu Y et al. RNA-Seq identifies novel myocardial gene expression signatures of heart failure. Genomics. 2015;105(2):83–9.PubMedCrossRef

28.

Ali SR et al. Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ Res. 2014;115(7):625–35.PubMedCrossRef

29.

Chu M et al. A novel role of CDX1 in embryonic epicardial development. PLoS One. 2014;9(7):e103271.PubMedPubMedCentralCrossRef

30.••

Nurnberg ST et al. Coronary artery disease associated transcription factor TCF21 regulates smooth muscle precursor cells that contribute to the fibrous cap. PLoS Genet. 2015;11(5):e1005155. This study using multiple functional and in vivo assays demonstrates that the TCF21 gene, one of the lead CAD GWAS hits, is indeed causal for CAD.PubMedPubMedCentralCrossRef

31.

Bell RD et al. Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. Arterioscler Thromb Vasc Biol. 2014;34(6):1249–59.PubMedPubMedCentralCrossRef

32.

Gutierrez-Arcelus M et al. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife. 2013;2:e00523.PubMedPubMedCentral

33.

Feinberg AP. Epigenomics reveals a functional genome anatomy and a new approach to common disease. Nat Biotechnol. 2010;28(10):1049–52.PubMedPubMedCentralCrossRef

34.

Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21(35):5427–40.PubMedCrossRef

35.

Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.PubMedPubMedCentralCrossRef

36.

Kim M et al. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One. 2010;5(3):e9692.PubMedPubMedCentralCrossRef

37.

Sharma P et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol. 2008;27(7):357–65.PubMedCrossRef

38.

Dick KJ et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014;383(9933):1990–8.PubMedCrossRef

39.

Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 1996;16(12):1509–15.PubMedCrossRef

40.

Putku M et al. CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs. Hum Genet. 2015;134(3):291–303.PubMedCrossRef

41.

Banovich NE et al. Methylation QTLs are associated with coordinated changes in transcription factor binding, histone modifications, and gene expression levels. PLoS Genet. 2014;10(9):e1004663.PubMedPubMedCentralCrossRef

42.

ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74.CrossRef

43.

Kundaje A et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–30.PubMedPubMedCentralCrossRef

44.

Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol. 2012;30(11):1095–106.PubMedPubMedCentralCrossRef

45.

Boyle AP et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790–7.PubMedPubMedCentralCrossRef

46.

del Rosario RC et al. Sensitive detection of chromatin-altering polymorphisms reveals autoimmune disease mechanisms. Nat Methods. 2015;12(5):458–64.PubMedCrossRef

47.

Hazelett DJ et al. Comprehensive functional annotation of 77 prostate cancer risk loci. PLoS Genet. 2014;10(1):e1004102.PubMedPubMedCentralCrossRef

48.

Yao L et al. Functional annotation of colon cancer risk SNPs. Nat Commun. 2014;5:5114.PubMedPubMedCentralCrossRef

49.

Miller CL et al. Disease-related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus. PLoS Genet. 2013;9(7):e1003652.PubMedPubMedCentralCrossRef

50.

Reschen ME et al. Lipid-induced epigenomic changes in human macrophages identify a coronary artery disease-associated variant that regulates PPAP2B Expression through Altered C/EBP-beta binding. PLoS Genet. 2015;11(4):e1005061.PubMedPubMedCentralCrossRef

51.

Creyghton MP et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A. 2010;107(50):21931–6.PubMedPubMedCentralCrossRef

52.

Mikkelsen TS et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007;448(7153):553–60.PubMedPubMedCentralCrossRef

53.

Gomez D et al. Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods. 2013;10(2):171–7.PubMedPubMedCentralCrossRef

54.

Crawford GE et al. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res. 2006;16(1):123–31.PubMedPubMedCentralCrossRef

55.

Schones DE et al. Dynamic regulation of nucleosome positioning in the human genome. Cell. 2008;132(5):887–98.PubMedCrossRef

56.

Hogan GJ, Lee CK, Lieb JD. Cell cycle-specified fluctuation of nucleosome occupancy at gene promoters. PLoS Genet. 2006;2(9):e158.PubMedPubMedCentralCrossRef

57.••

Buenrostro JD et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods. 2013;10(12):1213–8. This study demonstrates the application of ATAC-Seq, a method for probing open chomatin regions, that dramatically reduces the number of cells needed for the experiment while preserving the resolution.PubMedPubMedCentralCrossRef

58.

Weintraub H, Groudine M. Chromosomal subunits in active genes have an altered conformation. Science. 1976;193(4256):848–56.PubMedCrossRef

59.

Enver T, Brewer AC, Patient RK. Simian virus 40-mediated cis induction of the Xenopus beta-globin DNase I hypersensitive site. Nature. 1985;318(6047):680–3.PubMedCrossRef

60.

Thurman RE et al. The accessible chromatin landscape of the human genome. Nature. 2012;489(7414):75–82.PubMedPubMedCentralCrossRef

61.

Bell O et al. Determinants and dynamics of genome accessibility. Nat Rev Genet. 2011;12(8):554–64.PubMedCrossRef

62.

Degner JF et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature. 2012;482(7385):390–4.PubMedPubMedCentralCrossRef

63.

Sazonova O et al. Characterization of TCF21 downstream target regions identifies a transcriptional network linking multiple independent coronary artery disease loci. PLoS Genet. 2015;11(5):e1005202.PubMedPubMedCentralCrossRef

64.

Winter DR et al. DNase-seq predicts regions of rotational nucleosome stability across diverse human cell types. Genome Res. 2013;23(7):1118–29.PubMedPubMedCentralCrossRef

65.

Schep AN et al. Structured nucleosome fingerprints enable high-resolution mapping of chromatin architecture within regulatory regions. Genome Res. 2015;25(11):1757–70.PubMedPubMedCentralCrossRef

66.

Dekker J et al. Capturing chromosome conformation. Science. 2002;295(5558):1306–11.PubMedCrossRef

67.

Harismendy O et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature. 2011;470(7333):264–8.PubMedPubMedCentralCrossRef

68.

Davison LJ et al. Long-range DNA looping and gene expression analyses identify DEXI as an autoimmune disease candidate gene. Hum Mol Genet. 2012;21(2):322–33.PubMedCrossRef

69.

Smemo S et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature. 2014;507(7492):371–5.PubMedPubMedCentralCrossRef

70.

Belton JM et al. Hi-C: a comprehensive technique to capture the conformation of genomes. Methods. 2012;58(3):268–76.PubMedCrossRef

71.

Fullwood MJ et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature. 2009;462(7269):58–64.PubMedPubMedCentralCrossRef

72.

Buenrostro JD et al. Single-cell chromatin accessibility reveals principles of regulatory variation. Nature. 2015;523(7561):486–90.PubMedPubMedCentralCrossRef

73.

Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(5):1104–15.PubMedPubMedCentralCrossRef

74.

Welcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.CrossRef

75.

Helgadottir A et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316(5830):1491–3.PubMedCrossRef

76.

McPherson R et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316(5830):1488–91.PubMedPubMedCentralCrossRef

77.

Samani NJ et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357(5):443–53.PubMedPubMedCentralCrossRef

78.

Helgadottir A et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet. 2008;40(2):217–24.PubMedCrossRef

79.

Congrains A et al. Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis. 2012;220(2):449–55.PubMedCrossRef

80.

Cunnington MS, Keavney B. Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus. Curr Atheroscler Rep. 2011;13(3):193–201.PubMedCrossRef

81.

Folkersen L et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One. 2009;4(11):e7677.PubMedPubMedCentralCrossRef

82.

Cunnington MS et al. Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genet. 2010;6(4):e1000899.PubMedPubMedCentralCrossRef

83.

Liu Y et al. INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One. 2009;4(4):e5027.PubMedPubMedCentralCrossRef

84.

Motterle A et al. Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Hum Mol Genet. 2012;21(18):4021–9.PubMedPubMedCentralCrossRef

85.

Holdt LM et al. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis. 2011;214(2):264–70.PubMedCrossRef

86.

Jarinova O et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol. 2009;29(10):1671–7.PubMedCrossRef

87.

Pilbrow AP et al. The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissues. PLoS One. 2012;7(6):e39574.PubMedPubMedCentralCrossRef

88.

Visel A et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature. 2010;464(7287):409–12.PubMedPubMedCentralCrossRef

89.

Gonzalez-Navarro H et al. p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis. J Am Coll Cardiol. 2010;55(20):2258–68.PubMedCrossRef

90.

Gizard F et al. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a. J Clin Invest. 2005;115(11):3228–38.PubMedPubMedCentralCrossRef

91.

Fuster JJ et al. Increased gene dosage of the Ink4/Arf locus does not attenuate atherosclerosis development in hypercholesterolaemic mice. Atherosclerosis. 2012;221(1):98–105.PubMedCrossRef

92.

Wouters K et al. Bone marrow p16INK4a-deficiency does not modulate obesity, glucose homeostasis or atherosclerosis development. PLoS One. 2012;7(3):e32440.PubMedPubMedCentralCrossRef

93.

Kuo CL et al. Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. Arterioscler Thromb Vasc Biol. 2011;31(11):2483–92.PubMedPubMedCentralCrossRef

94.

Leeper NJ et al. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol. 2013;33(1):e1–10.PubMedCrossRef

95.

Kojima Y et al. Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest. 2014;124(3):1083–97.PubMedPubMedCentralCrossRef

96.

Kim JB et al. Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice. Circulation. 2012;126(15):1896–906.PubMedPubMedCentralCrossRef

97.

Schunkert H et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333–8.PubMedPubMedCentralCrossRef

98.

Miller CL et al. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet. 2014;10(3):e1004263.PubMedPubMedCentralCrossRef

99.

Lu J, Richardson JA, Olson EN. Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech Dev. 1998;73(1):23–32.PubMedCrossRef

100.

Acharya A et al. Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis. 2011;49(11):870–7.PubMedPubMedCentralCrossRef

101.

Acharya A et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development. 2012;139(12):2139–49.PubMedPubMedCentralCrossRef

102.

Braitsch CM et al. Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart. Dev Biol. 2012;368(2):345–57.PubMedPubMedCentralCrossRef

103.

Mali P, Esvelt KM, Church GM. Cas9 as a versatile tool for engineering biology. Nat Methods. 2013;10(10):957–63.PubMedPubMedCentralCrossRef

104.

Gupta RM, Musunuru K. Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9. J Clin Invest. 2014;124(10):4154–61.PubMedPubMedCentralCrossRef

105.

Miller CL et al. Dissecting the causal genetic mechanisms of coronary heart disease. Curr Atheroscler Rep. 2014;16(5):406.PubMedPubMedCentralCrossRef

106.

Nagiec MM et al. Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression. PLoS One. 2015;10(3):e0120295.PubMedPubMedCentralCrossRef

107.

Beaudoin M et al. Myocardial infarction-associated SNP at 6p24 interferes with MEF2 binding and associates with PHACTR1 expression levels in human coronary arteries. Arterioscler Thromb Vasc Biol. 2015;35(6):1472–9.PubMedPubMedCentralCrossRef

108.

Ding Q et al. Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. Circ Res. 2014;115(5):488–92.PubMedPubMedCentralCrossRef

109.

Bauer DE et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342(6155):253–7.PubMedPubMedCentralCrossRef

110.

Canver MC et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature. 2015;527(7577):192–7.PubMedPubMedCentralCrossRef

Title: Genetics and Genomics of Coronary Artery Disease
Authors: Milos Pjanic
Clint L. Miller
Robert Wirka
Juyong B. Kim
Daniel M. DiRenzo
Thomas Quertermous
Publication date: 01-10-2016
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 10/2016
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-016-0777-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Genetics and Genomics of Coronary Artery Disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2016

BP Targets in Hypertension: What Should We Do Now That SPRINT Is Out?

Transcatheter Aortic Valve Replacement in Lower Surgical Risk Patients: Review of Major Trials and Future Perspectives

Psychosocial Factors in Diabetes and Cardiovascular Risk

Post-traumatic Stress Disorder and Cardiovascular Disease

Rheumatic Heart Disease in the Twenty-First Century

Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach